Global Transcriptomics Technologies Market: The Rising Role of Bioinformatics

 

The global transcriptomics technologies market is witnessing significant growth, driven by increasing investments in life sciences research, personalized medicine, and advanced drug discovery. Transcriptomics—the study of the complete set of RNA transcripts produced by cells—has become an important tool for understanding gene expression and identifying disease-specific biomarkers. As pharmaceutical and biotechnology companies increasingly focus on targeted and personalized therapeutics, demand for transcriptomics technologies continues to rise.

Growing Demand for Personalized Medicine

One of the major factors supporting the expansion of the transcriptomics technologies market is the growing emphasis on personalized healthcare. Pharmaceutical companies are investing heavily in the identification of biomarkers that can help predict disease progression and treatment responses. Transcriptomic analysis enables researchers to examine gene expression patterns and gain valuable insights into disease mechanisms, supporting the development of more effective and targeted therapies.

In addition, rising research and development expenditure and improvements in healthcare infrastructure are creating favorable conditions for market growth. Academic institutions, pharmaceutical companies, and research organizations are increasingly adopting advanced transcriptomics platforms to accelerate scientific discoveries.

The development of bioinformatics tools and services is also expected to create lucrative opportunities. The growing volume and complexity of biological research data have increased the need for sophisticated software capable of processing, storing, and interpreting large datasets. This creates opportunities for both life science companies and software developers to introduce innovative bioinformatics solutions.

The market opportunity was valued at approximately US$2.55 billion in 2015 and was projected to expand at a 15.9% CAGR between 2013 and 2019, reaching around US$4.62 billion by 2019.

PCR and Next-Generation Sequencing Drive Technology Adoption

By technology, polymerase chain reaction (PCR) remained a leading contributor to market revenue through 2019. PCR's high process efficiency, precision, amplification capabilities, and broad range of applications have supported its widespread adoption. Continuous product innovation and improvements in PCR-based technologies have further strengthened its position.

Meanwhile, next-generation sequencing (NGS) emerged as one of the fastest-growing technology segments. The segment was projected to expand at a CAGR of more than 19% during the forecast period. Rapid technological advancements, the ability to analyze cellular transcriptomes from multiple dimensions, expanding applications, and increasing outsourcing of sequencing services are among the key factors supporting NGS adoption.

Drug Discovery Remains a Key Application

Among applications, drug discovery and research represented the dominant segment in 2015 and was expected to maintain its leadership through 2019. Increasing research activities in genomics and proteomics are encouraging pharmaceutical and biotechnology companies to incorporate transcriptomics into drug development programs.

The drug discovery and research segment was projected to grow at a significant 18.2% CAGR during the forecast period, reflecting the increasing importance of gene-expression analysis in identifying therapeutic targets and understanding disease biology.

North America Leads the Global Market

North America was expected to remain the leading regional market through 2019, supported by extensive research and development activities, advanced technological infrastructure, and the presence of numerous biotechnology companies. Increasing private-sector investments in transcriptomics research are helping organizations develop targeted therapeutics, while universities and research institutes continue to conduct extensive transcriptome studies.

The region was projected to account for approximately 39% of global market revenue by 2019.

Meanwhile, Asia Pacific was expected to record an impressive CAGR of 18.0%. Growing life sciences research, expanding healthcare capabilities, and increasing outsourcing of clinical and medical research in countries such as India and China are contributing to regional growth.

Competitive Landscape

The transcriptomics technologies market features several prominent companies, including Affymetrix Inc., Agilent Technologies, F. Hoffmann-La Roche Ltd., Illumina Inc., Life Technologies Corporation, and Thermo Fisher Scientific. Continued technological innovation, strategic investments, and the development of advanced sequencing and analysis solutions are expected to shape competition in the market.

Overall, increasing demand for personalized medicine, expanding genomics research, technological advancements, and the growing importance of bioinformatics are expected to create promising opportunities for the transcriptomics technologies market.

Media Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Global Polyvinyl Alcohol Market Forecast: Growth Prospects and Emerging Applications

 

The global polyvinyl alcohol (PVA) market is witnessing growing demand across packaging, construction, textiles, paper, and other industrial applications. Polyvinyl alcohol, also known as PVOH, is a hydrophilic, colorless, and water-soluble synthetic polymer recognized for its excellent film-forming, adhesive, and chemical-resistant properties. It is generally produced by polymerizing vinyl acetate monomer followed by hydrolysis. Its versatile characteristics have made PVA an important material for a wide range of commercial and industrial applications.

Rising Demand in Food Packaging

Food packaging represents an important application area for polyvinyl alcohol. PVA can be used as a coating and binding material where moisture protection and barrier properties are required. Its film-forming capabilities help protect sensitive food ingredients from moisture, oxygen, and other external factors.

The material can also help mask unwanted flavors and odors while supporting convenient handling and consumption. As consumers increasingly demand convenient, functional, and sustainable packaging solutions, manufacturers are exploring advanced materials that can improve product protection while reducing environmental impact.

Changing lifestyles, rising purchasing power in emerging economies, growth in out-of-home consumption, and increasing demand for easy-to-use packaging are expected to support opportunities for PVA-based solutions.

Get Sample PDF Copy: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2948

Construction Industry Creates New Opportunities

The construction industry is another significant area of opportunity for polyvinyl alcohol. PVA is used in cement and concrete applications because it can improve properties such as viscosity, particle dispersion, water solubility, and adhesion. PVA fibers can also serve as reinforcing materials in fiber-reinforced concrete.

Growing infrastructure development across Asia Pacific, particularly in countries such as China, India, and Japan, is expected to contribute to demand. The increasing adoption of PVA fibers as an alternative to asbestos in selected construction applications is also creating opportunities because asbestos is associated with serious health concerns.

Sustainability and Bio-Based Products

Sustainability is emerging as a major factor influencing the future of the polyvinyl alcohol market. Increasing restrictions on waste disposal, limited landfill capacity, and growing environmental awareness are encouraging businesses to seek more sustainable materials and packaging solutions.

Demand for bio-based and environmentally preferable PVA products is therefore expected to increase as manufacturers and consumers place greater emphasis on sustainability. Packaging producers are particularly focused on materials that can deliver functionality while addressing evolving environmental requirements.

Polyvinyl Alcohol Fibers Market Outlook

Polyvinyl alcohol fibers are manufactured from PVA resins and are valued for their high tenacity, high Young's modulus, low creep, low elongation, and resistance to chemicals, ultraviolet radiation, and challenging weather conditions.

These fibers are widely used in textiles, fabrics, clothing, nonwovens, cement additives, ropes, fishing nets, and tire cords. In textile applications, PVA fibers offer good water affinity and a cotton-like feel. Products made with these fibers can also provide convenient washing and drying characteristics.

The market can broadly be divided into staple fibers and filaments. Staple fibers have traditionally represented an important segment because of their use in cement additives, textiles, nonwoven materials, and twisted yarns. Filaments are also expected to witness opportunities as manufacturers develop new applications.

Asia Pacific Leads Market Activity

Asia Pacific remains a key region for PVA fiber production and consumption, with significant manufacturing activity concentrated in China and Japan. The region benefits from expanding construction, textile, manufacturing, and infrastructure sectors.

North America and Europe are also important markets, particularly for applications involving PVA fibers as alternatives to asbestos in cement-related products. Meanwhile, Latin America and the Middle East & Africa are expected to offer additional opportunities as industrial development and application adoption increase.

The competitive landscape includes major companies such as Kuraray Co., Ltd., Unitika Ltd., Anhui Wanwei Group, Sinopec SVW, Nitivy Ltd., Nycon Corporation, and MiniFiber. Overall, continued investment in sustainable materials, infrastructure, packaging, and advanced fiber applications is expected to support the long-term development of the global polyvinyl alcohol market.

Media Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

U.S. Healthcare Sector Explores Recycling to Reduce Medical Plastic Waste

 

The growing use of plastic across the healthcare industry has transformed the way medical devices, packaging, and disposable products are manufactured. However, increasing environmental concerns surrounding plastic waste are encouraging healthcare organizations, manufacturers, and policymakers to explore recycling and sustainable alternatives.

Healthcare facilities across the U.S. generate thousands of tons of waste every day, with plastic accounting for a significant share. Medical plastics are widely used in products such as syringes, catheters, IV tubes, medical bags, diagnostic equipment, and surgical instruments because they offer a combination of durability, flexibility, lightweight construction, low manufacturing costs, and sterilization capabilities.

Despite these advantages, the extensive use of single-use medical plastics has attracted growing scrutiny. Government agencies, industry organizations, and recycling initiatives are increasingly emphasizing the need to improve the collection, segregation, and recycling of medical plastic waste.

Single-Use Plastics Remain Essential in Healthcare

Single-use plastic products continue to play an important role in hospitals and healthcare facilities. Their ability to provide hygienic and sterile solutions makes them particularly valuable in environments where infection prevention is critical.

Products such as disposable gloves, syringes, insulin pens, IV tubes, surgical equipment, and catheters can reduce contamination risks by eliminating the need for repeated sterilization. Their relatively low cost and convenient disposal have further contributed to their widespread adoption.

However, the environmental impact of these products has encouraged healthcare providers to reconsider how and when disposable plastics are used. Some hospitals are exploring reusable alternatives, including reusable sterilization containers, to reduce dependence on disposable packaging and medical materials.

Get Sample PDF Copy: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77926

Material Properties Continue to Drive Market Demand

The favorable physical and functional properties of medical plastics remain key factors supporting market growth. Polyvinyl chloride (PVC), polyethylene, polypropylene, polystyrene, silicone, and engineering plastics are commonly used in medical applications.

PVC has historically maintained a strong position because of its affordability, flexibility, toughness, abrasion resistance, and ease of processing. It is widely used in disposable medical devices and tubing.

Meanwhile, polypropylene is gaining attention because of its resistance to cracking, chemicals, and electrolytes, along with its high melting point. The material is used in applications ranging from medical vials and specimen containers to diagnostic products and intravenous bottles.

Advanced engineering plastics such as PEEK, PEI, PES, PSU, and TPU are also finding applications where higher performance and durability are required.

COVID-19 Accelerated Demand for Medical Plastics

The COVID-19 pandemic highlighted the importance of disposable medical products. Demand for surgical gloves, masks, gowns, respirators, syringes, medical bags, and other protective equipment increased significantly as healthcare systems prioritized infection control.

This surge reinforced the importance of medical plastics while simultaneously increasing concerns about the volume of healthcare waste generated. As a result, recycling technologies and more sustainable material-management practices have become increasingly important areas of focus.

Recycling and Sustainable Solutions Create New Opportunities

The future of the U.S. medical plastics industry is likely to depend on its ability to balance healthcare requirements with environmental sustainability. Manufacturers are increasingly investigating recyclable materials, improved waste-separation systems, reusable products, and technologies capable of recovering valuable plastics from medical waste streams.

Innovation in 3D printing is another potential growth opportunity. Plastics used in additive manufacturing can support the production of customized prosthetics, orthotic devices, implants, and certain medical instruments while reducing development time and material waste in some applications.

With environmental regulations becoming more stringent and healthcare organizations facing pressure to reduce waste, recycling could become an increasingly important component of the medical plastics value chain.

Overall, the U.S. medical plastics market continues to benefit from strong demand for affordable, lightweight, durable, and sterilizable materials. At the same time, mounting environmental concerns are pushing market participants toward a more circular approach. Companies that can combine medical-grade performance with recyclability and sustainable manufacturing practices are likely to be better positioned for long-term growth.

Media Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453